Potassium, glucose, and insulin in treatment of myocardial infarction.

Open Access
Publisher Website
Google Scholar
Abstract
A further 200 patients, with a confirmed diagnosis of myocardial infarction, were treated with a K, insulin, and glucose regimen since the conclusion of a statistically controlled sequential trial of this treatment in June 1965. The results of that trial are confirmed in that identical fatality rates were observed in the post-trial series (17.5%) and the treated group of the trial (16.5%). The treatment is more beneficial to men than women, probably because men are more prone to die of an arrhythmia than women and the regimen is principally effective by causing a reduction in the number of deaths due to arrhythmias.